Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Thyroid hormone resistance Stories

2012-08-20 00:20:05

Tokyo, Aug 20, 2012 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has received orphan drug designation from Japan's Ministry of Labour, Health and Welfare for its multikinase inhibitor lenvatinib mesylate ("lenvatinib") for the treatment of thyroid cancer, the drug's prospective indication.Lenvatinib, discovered and being developed in-house, is an anti-angiogenic agent with a unique inhibitory profile against the receptor tyrosine kinase family of kinases. It is a potent...

2012-07-17 06:25:07

SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, Mass., July 17, 2012 /PRNewswire/ -- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced the publication of new data suggesting that routine clinical use of Veracyte's Afirma® Gene Expression Classifier helps to significantly reduce the number of surgeries performed on patients whose thyroid nodule cytology results...

2012-06-27 06:25:17

GLEN ALLEN, Va., June 27, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) announced today that the results of a successful animal study supporting the potential thyroid benefit of nutritional supplementation with Rock Creek Pharmaceuticals' anatabine supplement, Anatabloc®, were presented on Tuesday, June 26, in Houston, Texas, at ENDO 2012, the annual international meeting of the Endocrine Society. (Logo: http://photos.prnewswire.com/prnh/20120301/NE62741LOGO ) The...

2012-01-09 08:00:00

SOUTH SAN FRANCISCO, Calif., Jan. 9, 2012 /PRNewswire/ -- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced that Palmetto GBA, a national contractor that administers Medicare benefits, has established coverage for the company's Afirma Gene Expression Classifier for use in thyroid nodule diagnosis. This means that Veracyte's genomic test is now accessible to 40 million Medicare patients nationwide....

2012-01-03 05:00:00

LOS ANGELES, Jan. 3, 2012 /PRNewswire/ -- TSH testing, the gold standard in hypothyroid diagnosis, may be misleading according to the studies quoted in a new article titled Hormone Replacement Therapy in the Geriatric Patient: Current State of the Evidence and Questions for the Future. Estrogen, Progesterone, Testosterone, and Thyroid Hormone Augmentation in Geriatric Clinical Practice. The article, independently written and published, is a broad study of hormone replacement in...

2011-11-10 09:00:00

SARASOTA, Fla., Nov. 10, 2011 /PRNewswire/ -- Amy Murray, a 35-year old mother of two, had a sore throat for weeks. When she begun to have trouble swallowing, she thought she might have strep throat, and went to see her doctor. He found a lump in her neck, and after several medical tests, Murray was diagnosed with papillary thyroid cancer. According to TMD Limited, a medical research company, Murray's research and ultimate decision to seek treatment outside of the US is typical of more...

2011-10-18 09:48:36

Scientists' discovery of new form of neonatal respiratory distress syndrome offers clues to treatments for infants who don't respond to steroid drugs A discovery by scientists at the Salk Institute for Biological Studies might explain why some premature infants fail to respond to existing treatments for a deadly respiratory distress syndrome (RDS) and offers clues for new ways to treat the breathing disorder. The scientists identified a new form of RDS in newborn mice and traced the...

2011-08-22 12:01:00

UPPSALA, Sweden and COPENHAGEN, Denmark, August 22, 2011 /PRNewswire/ -- Phadia AB and Biomonitor A/S announced today a collaboration in the field of immunogenicity testing and monitoring of patients treated with biopharmaceutical drugs. (Logo: http://www.newscom.com/cgi-bin/prnh/20101208/425503 ) "The addition of BioMonitor's iLite technology to our portfolio makes us the most complete supplier of solutions for Anti-Drug Antibody (ADA) testing," says Hans...

2011-07-11 20:23:31

There is no difference between brand-name and generic drug formulations of amiodarone "” taken to control arrhythmia "“ in the incidence of thyroid dysfunction, according to a study in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/site/embargo/cmaj101800.pdf. Amiodarone, prescribed to control irregular heartbeats, is known for causing hypo- and hyper-thyroidism. Amiodarone is available in Canada in brand-name formulations as well as less...

2011-04-07 00:00:26

Growth Hormones Direct announces hormone optimization treatment is not just for Growth Hormone deficiency anymore...many are turning to homeopathic Growth Hormones as a treatment for stress and stress related disorders. Phoenix, AZ (Vocus/PRWEB) April 06, 2011 Growth Hormones Direct announces hormone optimization treatment is not just for Growth Hormone deficiency anymore...many are turning to homeopathic Growth Hormones as a treatment for stress and stress related disorders. One of the...